Combined use of MR fat quantification and MR elastography in living liver donors: Can it reduce the need for preoperative liver biopsy?

Radiology

Volumn 276, Issue 2, 2015, Pages 453-464

  Yoon, Jeong Hee ^a   Lee, Jeong Min ^a,b   Suh, Kyung Suk ^a   Lee, Kwan Woong ^a   Yi, Nam Joon ^a   Lee, Kyung Bun ^a   Han, Joon Koo ^a,b   Choi, Byung Ihn ^a,b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DIGESTIVE TRACT PARAMETERS; ELASTOGRAPHY; FATTY LIVER; FEMALE; HEPATITIS; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; LIVER PARENCHYMA; LIVER STIFFNESS; LIVER TRANSPLANTATION; LIVING DONOR; MAGNETIC RESONANCE ELASTOGRAPHY; MAGNETIC RESONANCE FAT QUANTIFICATION; MALE; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; VALIDATION PROCESS; ADOLESCENT; BIOPSY; DONOR SELECTION; EVALUATION STUDY; LIVER; LIVER CIRRHOSIS; MIDDLE AGED; MULTIMODAL IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; UTILIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; BIOPSY; DONOR SELECTION; ELASTICITY IMAGING TECHNIQUES; FATTY LIVER; FEMALE; HUMANS; LIVER; LIVER CIRRHOSIS; LIVING DONORS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MULTIMODAL IMAGING; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84938709472     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.15140908     Document Type: Article

References (49)

1. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334(11):693-699.
2. Adam R, McMaster P, O'Grady JG, et al. Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transpl 2003;9(12):1231-1243.
3. Trotter JF. Selection of donors and recipients for living donor liver transplantation. Liver Transpl 2000;6(6 Suppl 2):S52-S58.
4. Kim KW, Lee J, Lee H, et al. Right lobe estimated blood-free weight for living donor liver transplantation: accuracy of automated blood-free CT volumetry - preliminary results. Radiology 2010;256(2):433-440.
5. Akabayashi A, Slingsby BT, Fujita M. The first donor death after living-related liver transplantation in Japan. Transplantation 2004;77(4):634.
6. Kiuchi T, Tanaka K, Ito T, et al. Small-for-size graft in living donor liver transplantation: how far should we go? Liver Transpl 2003;9(9):S29-S35.
7. Sharma A, Ashworth A, Behnke M, Cotterell A, Posner M, Fisher RA. Donor selection for adult-to-adult living donor liver transplantation: well begun is half done. Transplantation 2013;95(3):501-506.
8. Tsang LL, Chen CL, Huang TL, et al. Preoperative imaging evaluation of potential living liver donors: reasons for exclusion from donation in adult living donor liver transplantation. Transplant Proc 2008;40(8):2460-2462.
9. Fan ST, Lo CM, Liu CL, Yong BH, Chan JK, Ng IO. Safety of donors in live donor liver transplantation using right lobe grafts. Arch Surg 2000;135(3):336-340.
10. Kemmer N, Neff GW, Franco E, et al. Non-alcoholic fatty liver disease epidemic and its implications for liver transplantation. Transplantation 2013;96(10):860-862.
11. Said A. Non-alcoholic fatty liver disease and liver transplantation: outcomes and advances. World J Gastroenterol 2013;19(48):9146-9155.
12. McCormack L, Dutkowski P, El-Badry AM, Clavien PA. Liver transplantation using fatty livers: always feasible? J Hepatol 2011;54(5):1055-1062.
13. Song GW, Lee SG, Hwang S, et al. Preoperative evaluation of biliary anatomy of donor in living donor liver transplantation by conventional nonenhanced magnetic resonance cholangiography. Transpl Int 2007;20(2):167-173.
14. Lee SS, Kim TK, Byun JH, et al. Hepatic arteries in potential donors for living related liver transplantation: evaluation with multidetector row CT angiography. Radiology 2003;227(2):391-399.
15. Schwenzer NF, Springer F, Schraml C, Stefan N, Machann J, Schick F. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol 2009;51(3):433-445.
16. Lee JY, Kim KM, Lee SG, et al. Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center. J Hepatol 2007;47(2):239-244.
17. Ryan CK, Johnson LA, Germin BI, Marcos A. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation. Liver Transpl 2002;8(12):1114-1122.
18. Park SH, Kim PN, Kim KW, et al. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology 2006;239(1):105-112.
19. Brandhagen D, Fidler J, Rosen C. Evaluation of the donor liver for living donor liver transplantation. Liver Transpl 2003;9(10 Suppl 2):S16-S28.
20. Nadalin S, Malagó M, Valentin-Gamazo C, et al. Preoperative donor liver biopsy for adult living donor liver transplantation: risks and benefits. Liver Transpl 2005;11(8):980-986.
21. Brown RS Jr, Russo MW, Lai M, et al. A survey of liver transplantation from living adult donors in the United States. N Engl J Med 2003;348(9):818-825.
22. Brancatelli G. Science to practice: Should biopsy be performed in potential liver donors when unenhanced CT shows an unacceptable degree of steatosis for transplantation? Radiology 2006;239(1):1-2.
23. Tang A, Tan J, Sun M, et al. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 2013;267(2):422-431.
24. Reeder SB, Cruite I, Hamilton G, Sirlin CB. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 2011;34(4):729-749.
25. Kim BH, Lee JM, Lee YJ, et al. MR elastography for noninvasive assessment of hepatic fibrosis: experience from a tertiary center in Asia. J Magn Reson Imaging 2011;34(5):1110-1116.
26. Chen J, Talwalkar JA, Yin M, Glaser KJ, Sanderson SO, Ehman RL. Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology 2011;259(3):749-756.
27. Manduca A, Oliphant TE, Dresner MA, et al. Magnetic resonance elastography: noninvasive mapping of tissue elasticity. Med Image Anal 2001;5(4):237-254.
28. Yin M, Talwalkar JA, Glaser KJ, et al. Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol 2007;5(10):1207-1213, e2.
29. Pineda N, Sharma P, Xu Q, Hu X, Vos M, Martin DR. Measurement of hepatic lipid: high-speed T2-corrected multiecho acquisition at 1H MR spectroscopy - a rapid and accurate technique. Radiology 2009;252(2):568-576.
30. Hu HH, Kim HW, Nayak KS, Goran MI. Comparison of fat-water MRI and single-voxel MRS in the assessment of hepatic and pancreatic fat fractions in humans. Obesity (Silver Spring) 2010;18(4):841-847.
31. Elhamy R, Heba GH, Sirlin CB, et al. Agreement of 2-, 3-, 4-, 5- and 6-echo MRI-PDFF with MRS-PDFF in 580 adults with known or suspected non-alcoholic fatty liver disease (NAFLD) [abstr]. In: Proceedings of the Twenty-Second Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2014; 0138.
32. Hines CD, Bley TA, Lindstrom MJ, Reeder SB. Repeatability of magnetic resonance elastography for quantification of hepatic stiffness. J Magn Reson Imaging 2010;31(3):725-731.
33. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41(6):1313-1321.
34. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996;24(2):289-293.
35. Park YN, Kim HG, Chon CY, et al. Histological grading and staging of chronic hepatitis standardized guideline proposed by the Korean Study Group for the Pathology of Digestive Diseases. Korean J Pathol 1999;33(5):337-346.
36. Zou KH, Tuncali K, Silverman SG. Correlation and simple linear regression. Radiology 2003;227(3):617-622.
37. Pascher A, Sauer IM, Walter M, et al. Donor evaluation, donor risks, donor outcome, and donor quality of life in adult-to-adult living donor liver transplantation. Liver Transpl 2002;8(9):829-837.
38. Valentín-Gamazo C, Malagó M, Karliova M, et al. Experience after the evaluation of 700 potential donors for living donor liver transplantation in a single center. Liver Transpl 2004;10(9):1087-1096.
39. Kang BK, Yu ES, Lee SS, et al. Hepatic fat quantification: a prospective comparison of magnetic resonance spectroscopy and analysis methods for chemical-shift gradient echo magnetic resonance imaging with histologic assessment as the reference standard. Invest Radiol 2012;47(6):368-375.
40. Kühn JP, Hernando D, Muñoz del Rio A, et al. Effect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging results. Radiology 2012;265(1):133-142.
41. Huwart L, Sempoux C, Salameh N, et al. Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index. Radiology 2007;245(2):458-466.
42. Yin M, Chen J, Glaser KJ, Talwalkar JA, Ehman RL. Abdominal magnetic resonance elastography. Top Magn Reson Imaging 2009;20(2):79-87.
43. Angele MK, Rentsch M, Hartl WH, et al. Effect of graft steatosis on liver function and organ survival after liver transplantation. Am J Surg 2008;195(2):214-220.
44. Yamamoto K, Takada Y, Fujimoto Y, et al. Nonalcoholic steatohepatitis in donors for living donor liver transplantation. Transplantation 2007;83(3):257-262.
45. Hwang S, Lee SG, Jang SJ, et al. The effect of donor weight reduction on hepatic steatosis for living donor liver transplantation. Liver Transpl 2004;10(6):721-725.
46. Nakamuta M, Morizono S, Soejima Y, et al. Short-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation. Transplantation 2005;80(5):608-612.
47. Jin YJ, Kim KM, Hwang S, et al. Exercise and diet modification in non-obese non-alcoholic fatty liver disease: analysis of biopsies of living liver donors. J Gastroenterol Hepatol 2012;27(8):1341-1347.
48. Vizzutti F, Arena U, Marra F, Pinzani M. Elastography for the non-invasive assessment of liver disease: limitations and future developments. Gut 2009;58(2):157-160.
49. Wang Y, Ganger DR, Levitsky J, et al. Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging. AJR Am J Roentgenol 2011;196(3):553-561.